MENU
+Compare
EDSA
Stock ticker: NASDAQ
AS OF
Dec 20, 04:59 PM (EDT)
Price
$1.65
Change
-$0.10 (-5.71%)
Capitalization
5.72M

EDSA Edesa Biotech Forecast, Technical & Fundamental Analysis

a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs.

Industry Biotechnology
EDSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for EDSA with price predictions
Dec 20, 2024

Momentum Indicator for EDSA turns negative, indicating new downward trend

EDSA saw its Momentum Indicator move below the 0 level on December 05, 2024. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 96 similar instances where the indicator turned negative. In of the 96 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EDSA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EDSA entered a downward trend on December 16, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for EDSA's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for EDSA just turned positive on November 21, 2024. Looking at past instances where EDSA's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EDSA advanced for three days, in of 229 cases, the price rose further within the following month. The odds of a continued upward trend are .

EDSA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EDSA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.028) is normal, around the industry mean (14.538). P/E Ratio (0.000) is within average values for comparable stocks, (87.654). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.759). EDSA has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (254.760).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EDSA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
EDSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

EDSA is expected to report earnings to rise 56.70% to -15 cents per share on December 13

Edesa Biotech EDSA Stock Earnings Reports
Q3'23
Est.
$-0.16
Q2'23
Beat
by $0.06
Q1'23
Est.
$-0.12
Q4'22
Beat
by $0.05
Q3'22
Beat
by $0.03
The last earnings report on August 11 showed earnings per share of -10 cents, beating the estimate of -15 cents. With 23.94K shares outstanding, the current market capitalization sits at 5.72M.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Spy Court
Phone
+1 289 800-9600
Employees
16
Web
https://www.edesabiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGB1.980.07
+3.66%
Taseko Mines Limited
BHR3.240.09
+2.86%
Braemar Hotels & Resorts
EVRG61.430.90
+1.49%
Evergy
FLG9.050.08
+0.89%
Flagstar Financial Inc
STSS1.88-0.01
-0.53%
Sharps Technology Inc

EDSA and Stocks

Correlation & Price change

A.I.dvisor tells us that EDSA and SNPX have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDSA and SNPX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDSA
1D Price
Change %
EDSA100%
-5.71%
SNPX - EDSA
33%
Poorly correlated
+19.49%
ORMP - EDSA
32%
Poorly correlated
-4.42%
RNAZ - EDSA
31%
Poorly correlated
-4.13%
PGEN - EDSA
29%
Poorly correlated
+5.07%
IPSC - EDSA
28%
Poorly correlated
+3.81%
More